期刊文献+

细胞因子在炎症性肠病相关性结直肠癌中的作用 被引量:1

原文传递
导出
摘要 结直肠癌是炎症性肠病的致命性并发症之一,严重威胁人类的健康。虽然炎症性肠病相关性结直肠癌仅占整个人群中结直肠癌的1%~2%,但其死亡人数却占炎症性肠病患者总死亡率的15%。一般认为活动性病程长或病变范围广的炎症性肠病患者罹患结直肠癌的风险明显增高。最近研究发现慢性炎症是肿瘤发生、发展过程中的独立危险因素之一。与原发性肿瘤不同的是,越来越多的证据显示在炎性反应中由上皮细胞和免疫细胞分泌的细胞因子在炎症性肠病相关性结直肠癌的发病过程中扮演着重要角色。本文将就细胞因子在炎症性肠病相关性结直肠癌中的意义作一综述。
出处 《中华消化杂志》 CAS CSCD 北大核心 2010年第2期142-144,共3页 Chinese Journal of Digestion
  • 相关文献

参考文献25

  • 1Herszenyi L,Miheller P,Tulassay Z.Carcinogenesis in inflammatory bowel disease.Dig Dis,2007,25:267-269.
  • 2Di Mari JF,Saada JI,Mifflin RC,et al.HETEs enhance IL-1-mediated COX-2 expression via augmentation of message stability in human colonic myofibroblasts.Am J Physiol Gastrointest Liver Physiol,2007,293:G719-728.
  • 3Tanaka T,Kohno H,Murakami M,et al.Colitis-related rat colon carcinogenesis induced by 1-hydroxy-anthraquinone and methylazoxymethanol acetate (Review).Oncol Rep,2000,7:501-508.
  • 4Makins R,Ballinger A.Interleukin-5 potentiates the growth response of Caco-2 cells to IGF-Ⅱ:a role in colonic carcinogenesis complicating ulcerative colitis? Growth Horm IGF Res,2005,15:215-222.
  • 5Iwagaki H,Hizuta A,Tanaka N.Interleukin-1 receptor antagonists and other markers in colorectal cancer patients.Scand J Gastroenterol,1997,32:577-581.
  • 6Grivennikov S,Karin E,Terzic J,et al.IL-6 and Star3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.Cancer Cell,2009,15:103-113.
  • 7Lin WW,Karin M.A cytokine-mediated link between innate immunity,inflammation,and cancer.J Clin Invest,2007,117:1175-1183.
  • 8Becker C,Fantini MC,Schramm C,et al.TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.Immunity,2004,21:491-501.
  • 9Sturlan S,Oberhuber G,Beinhauer BG,et al.Interleukin-10-deficient mice and inflammatory bowel disease associated cancer development.Carcinogenesis,2001,22:665-671.
  • 10Sato Y,Takahashi S,Kinouchi Y,et al.IL-10 deficiency leads to somatic mutations in a model of IBD.Carcinogenesis,2006,27:1068-1073.

同被引文献10

  • 1Delaunoit T,Limburg PJ,Goldberg RM,et al.Colorectal cancer prognosis among patients with inflammatory bowel disease[J].Clin Gastroenterol Hepatoi,2006,4(3):335-342.
  • 2Simmons DL,Botting RM,Hla T.Cyclooxygenase isozymes:the biology of prostaglandin synthesis and inhibition[J].Pharmacol Rev,2004,56(3):387-437.
  • 3Sinicrope FA,Gill S.Role of cyclooxygenase-2 in colorectal cancer[J].Cancer Metastasis Rev,2004,23(1-2):63-75.
  • 4Cox DG,Pontes C,Guino E,et al.Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2(PTGS2/COX2)and risk of colorectal cancer[J].Br J Cancer,2004,91(2):339-343.
  • 5Tan W,Wu J,Zhang X,et al.Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurance and advanced disease status of colorectal cancer[J].Carcinogenesis,2007,28(6):1197-1201.
  • 6Driver JA,Gaziano JM,Gelber RP,et al.Development of a risk score for colorectal cancer in men[J].Am J Med,2007,120(3):257-263.
  • 7陈敏,夏冰,胡正国,杨桂芳,M.M.Gerrits,E.J.Kuipers.肠上皮细胞DNA含量变化与炎症性肠病癌变相关性的研究[J].临床内科杂志,2010,27(6):423-425. 被引量:6
  • 8高婷花,钱晓萍,刘宝瑞.环氧化酶-2基因多态性与肿瘤遗传易感性研究进展[J].现代肿瘤医学,2011,19(2):364-367. 被引量:4
  • 9周东风,李扬,庞国栋,梁忆波,崔琳.直肠癌远端移形黏膜COX-2及BCL-2蛋白的表达与临床意义[J].中华胃肠外科杂志,2011,14(6):448-451. 被引量:1
  • 10么鸿雁,陈辉,吕美霞,余红平,杨念念,方亚,段纪俊,施侣元.行为生活方式对恶性肿瘤发病影响的综合分析[J].中国公共卫生,2003,19(4):407-408. 被引量:33

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部